News

Fallopian Tube Cancer Pipeline Outlook Report 2025: Key 70+ Companies And Breakthrough Therapies Shaping The Future Landscape

DelveInsight's,“ Fallopian Tube Cancer Pipeline Insight 2025 ” report provides comprehensive insights about 70+ Fallopian ...
CURE1h

Keytruda and Padcev Generate Positive Topline Findings in Bladder Cancer

Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...
Renal & Urology News2h

Enfortumab Vedotin Plus Pembrolizumab Show Early Efficacy vs Surgery Alone for MIBC

The promising trial results may be a breakthrough for cisplatin-ineligible patients with muscle-invasive bladder cancer.